PMID: 4890206Mar 22, 1969Paper

Serotyping for homotransplantation. XXII. Specificity of cytotoxic antibodies developing after renal transplantation

British Medical Journal
P J MorrisP I Terasaki

Abstract

Cytotoxic antibodies against allogeneic lymphocytes were detected in 13 patients after removal of a renal allograft. Antibodies were not detected in seven patients who had grafts in situ for less than two months, but were detected in 13 out of 17 patients who had grafts in situ for longer than two months. The HL-A specificity of these positive sera was compatible with the HL-A antigen mismatch of the donor-recipient pairs in most instances, providing further evidence that such antibodies result from direct sensitization by the allograft and may play some part in renal allograft rejection.

References


❮ Previous
Next ❯

Citations

Aug 5, 1976·The New England Journal of Medicine·R B EttengerR N Fine
Jan 2, 2007·Transplantation·Peter J Morris
Aug 14, 2008·Transplantation·Paul I Terasaki, Junchao Cai
Jun 1, 1994·Transplant Immunology·B K Shenton
Dec 6, 2011·Seminars in Immunology·Jean KwunStuart J Knechtle
Jan 2, 2016·Clinical Biochemistry·Patrice VallinSacha A De Serres
May 1, 1972·The Journal of Surgical Research·C M Balch, A G Diethelm
Jan 4, 2015·Transplantation Reviews·Philip S MacklinSimon R Knight
Nov 7, 2014·Frontiers in Immunology·Giovanni PiottiCarlo Buzio
Mar 8, 2000·Transplantation·R M McKennaP I Terasaki
Aug 1, 1969·The Australian and New Zealand Journal of Surgery·P J Morris
Jun 5, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Paul I Terasaki
Aug 6, 2014·Transplantation·Anthony P Monaco, Peter J Morris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.